Biond Biologics Ltd announced that it has received $15 million in a round of funding led by new investor Deep Insight on November 3, 2021. The transaction also included participation from new investors including Heritage group, and existing investors including Harel Insurance Investments & Financial Services Ltd. As part of the transaction, Barak Ben Eliezer of Deep Insight will join the board of directors of the company.